EDITORIAL SECTIONS
RESEARCH & DEVELOPMENT
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
CLINICAL TRIALS
Real-world Evidence
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
MANUFACTURING
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Information Technology
Challenges and Advantages of Using Artificial Intelligence in Pharma
Many advanced largescale AI initiatives still need to be proved successful in Pharma
KNOWLEDGE BANK
Interviews
Breaking Bottlenecks in Continuous Biomanufacturing
Associate Professor, Engineering Product Development, Singapore University of Technology & Research (SUTD)
Shireen Goh Scientific CoFounder of Celltomix and Associate Professor at SUTD is pioneering densesuspension microfluidics to enable clogfree continuous biomanufacturing Her earlier work codeveloped the Erbi microbioreactor acquired by Merck underscoring her track record in academic translation
Articles
Nanovaccines
Vaccination represents the most efficacious tool for the prevention as well as control of infectious diseases accentuating the importance of safe and effective vaccines for preserving global health and enhancing economic growth Moreover the COVID pandemic of further highlighted the imperative role of various advanced technologies including nanotechnology in particular for hastening the developmen...
Research Insights
Factors to consider in developing individual pharmaceutical product quality risk profiles useful to government procurement agencies
Abstract Governments that procure pharmaceutical products from an Essential Medicine List EML bear special responsibility for the quality of these products In this article we examine the possibility of developing a pharmaceutical product quality risk assessment scheme for use by government procurement officials We use the Chinese EML as a basis and US recal
Case Studies
Case Study: Has The Increase In The Availability Of Generic Drugs Lowered The Price Of Cardiovascular Drugs In South Africa?
Abstract The aim of this study was to examine the relationship between originator drug pricing and the number of available generic brands within the cardiovascular drug class in the context of SEP legislation and to compare South African drug prices with international drug prices Background
Techno Trends
Praxis Introduces Breakthrough Elsunersen Therapy for Treating SCN2A Developmental and Epileptic Encephalopathy
Praxis Precision Medicines has introduced elsunersen PRAX for the treatment of seizures associated with SCNA developmental and epileptic encephalopathy SCNADEE caused by gainoffunction variants in the SCNA gene
White Papers
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS
TOP ARTICLES
Endocrine Disrupting Compounds (EDCs)
Sintu Kumar Samanta has been working as an Assistant professor in IIIT Allahabad, India. He did Ph.D. and post-doctoral research from IIT Kharagpur and IISc Bangalore, India respectively. He is working in the area of Biochemistry and Nanobiotechnology. He published research work in several international journals and filed one Indian patent.
Pavan Kumar Gautamis presently working as a Post-Doctoral Fellow in the Department of Applied Sciences at IIIT Allahabad, India. He obtained Ph.D. from the University of Allahabad, India. His area of research is synthesis of nanoparticles for water remediation. He published his research work in many international journals.
Blockchain for Data Integrity in Biopharma
Reshma Kodumuru is a Computer System Validation (CSV) leader at KBI Biopharma with expertise in data integrity and regulatory compliance. She specialises in designing and implementing validation frameworks that enhance operational efficiency within the biopharmaceutical industry, bridging complex data systems with strategic, compliant, and effective business solutions.
Synbiotics in Metabolic Health
Dr. Neeraj Mishra is working as Professor and Head, Department of Pharmaceutics, in Amity Institute of Pharmacy, Gwalior since July 2019. He has around twenty years of teaching and research experience. He has more than 100 publications of International and National repute in recent concepts of novel drug delivery systems, localised drug delivery, targeted and controlled drug delivery of nanocarriers/ microparticles for the treatment of breast, colon cancer, and neurodegenerative disorders. Dr. Mishra more than 3700 citations with h- index 32. The total cumulative Impact Factor of his published papers is more than 300 (as per SCOPUS). He has also written 15 Books and 30 book chapters in Elsevier, Bentham, Springer and Wiley Publication etc. He has also been granted 3 international patents and 2 Indian patents. Dr. Mishra is recipient of “Distinguished Professor Award” 2019 from DST-NSTMIS, SPAICS, Indore, and M.P. in September 2019. Dr. Mishra has received the “Distinguished Professor Award '' 2021 from Indian Pharmaceutical Association, MP State Branch, Indore. Dr Mishra has received Best Academician Award in the Indian Pharmacy Graduate Association, M.P. State International Conference held on 06th May 2023 at DAVV Auditorium, Indore, India.
Dr. Devyani Rajput is working as an Assistant Professor, Department of Pharmacognosy, in Amity Institute of Pharmacy, Gwalior since Jan 2024. She has around seven years of research experience. Her expertise includes nanotechnology, phytomedicine, and advanced drug delivery systems, with notable contributions to cancer research. She has participated in various national and international conferences, published impactful research, and received prestigious awards, including the BEST SCHOLAR AWARD 2023. She has more than 150 citations with h- index 3. She has received the CSIR travel Grant in April 2024 for presenting her research work in Istanbul University.
Nanoemulsion - A Promising Nanocarrier for Dermal Drug Delivery in Psoriasis
Sindhoor S M is currently working as an Assistant Professor in the Department of Pharmaceutics at Sri Adichunchanagiri College of Pharmacy, Mandya, Karnataka. His areas of specialisation include nanotechnology-based drug delivery system, lipid-based formulations, Topical delivery and gastroretentive in situ gel systems. He has published eight papers based on nanotechnology and lipid-based drug delivery system in peer reviewed indexed journals. Presently he is involved in the development of lipid-based delivery systems.
Marina Koland, is Professor and Head of the Department of Pharmaceutics at the NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to be University), Mangalore. Her area of specialisation in research is mucoadhesive and nanoparticulate drug delivery. She has published 50 research papers in peer reviewed journals, presented papers at 10 National and 3 International Conferences and worked on several Nitte University funded projects. She is currently working on solid lipid nanoparticles and micelles as drug carriers for targeting.
Detangling the Diagnostic Odyssey in Neurodevelopmental Disorder by Genomic Consultancy
Emili is a well-known genetic consultant with vast experience in cytogenetics, molecular biology with special emphasis in neurobiology. She is doing human genetics for past 22 years and now is practising genetic counselling as well as continuing her passion for research.
Koutilya basically is an academician in Zoology and has research interest in areas like anti-microbial peptides of amphibians, bio-active components of amphibians and genetic aspects of human reproductive disorder.
press releasesRead more...
Expert Shares Why ADC Development is Demanding a New Level of Bioconjugation Expertise
Antibodydrug conjugates have moved from a promising concept to one of the most actively developed drug classes in oncology Behind that progress lies a manufacturing challenge that is becoming more demanding by the year
Hengrui Pharma and Novo Enter Exclusive License Agreement for Once-Weekly Oral GLP-1/GIP Dual Receptor Agonist HRS-1596
Hengrui Pharma SH HK today announced that it has entered into a license agreement with Novo Nordisk Novo for HRS a phase Iready glucagonlike peptide receptor GLPR
Quotient Sciences and Acesion Pharma Announce Collaboration on AI-Enhanced Formulation Development to Advance Atrial Fibrillation Pipeline
Quotient Sciences a global integrated CRDMO contract research development and manufacturing organization and Acesion Pharma a Copenhagenbased biotech company developing treatments
Chugai and InxMed Enter into a Worldwide License Agreement for SPYK04, a RAF-MEK Molecular Glue
Chugai Pharmaceutical Co Ltd TOKYO hereafter Chugai and InxMed Hong Kong Limited hereafter InxMed today announced that they have entered into a worldwide license
Knight Therapeutics Enters into Exclusive Distribution Agreement with Kyowa Kirin International for Poteligeo® (Mogamulizumab)
Knight Therapeutics Inc Knight TSX GUD a panAmerican exUS pharmaceutical company announced today the signing of an exclusive distribution agreement with Kyowa Kirin International KKI a
BIX 2026 Names Canada as Country of Honor Showcasing Bioindustry Trends from BCI To Biotech Foods
BIOPLUSINTERPHEX KOREA BIX Koreas largest biotechnology and pharmaceutical convention will be held at COEX in Seoul from October to Supported by the Ministry of Trade Industry and Resources this years BIX will feature over companies from around the world Canada will participate as the Country o...
EventsRead more...
28 - 01
Sep 2026Discovery on Target 2026
Boston, MA, USA
29 - 01
Sep 202610th IPF Summit 2026
Boston, MA, USA
29 - 01
Sep 2026Powtech Technopharm 2026
Nuremberg, Germany
30 - 01
Sep 2026Pharma Launch Excellence Summit
Hyatt Regency Boston Harbor, B...
01 - 01
Oct 2026Articulate 2026: The Communication Revolution
Philadelphia, United States
05 - 06
Oct 2026ISPSAI France 2026
Paris, France
05 - 08
Oct 202616th World CB & CDx Summit 2026
Boston, MA, USA
12 - 13
Oct 2026Pharmaceutics 2026
Village Hotel Changi, Singapor...
LATEST NEWSRead more...
CAS and Novartis Collaborate to Advance AI-Ready Reaction Data
CAS has announced a collaboration with Novartis Biomedical Research to improve access to reaction data and support the use of artificial intelligence in scientific research
AbbVie Partners with Valkai to Expand AI Use in Clinical Development
AbbVie has partnered with Valkai to expand the use of AI across selected areas of clinical development
Turbine and Daiichi Sankyo Expand ADC Discovery Collaboration
Turbine and Daiichi Sankyo have expanded their collaboration to support antibodydrug conjugate ADC discovery using computational modelling
TriSalus Receives FDA Clearance for TriNav Advance for Liver Embolisation
TriSalus Life Sciences has received k clearance from the US Food and Drug Administration FDA for TriNav Advance a new device within its PressureEnabled Drug Delivery PEDD portfolio for liverdirected embolisation procedures
SK pharmteco and GEMMABio Expand Manufacturing Collaboration for SMA Gene Therapy
SK pharmteco and Gemma Biotherapeutics GEMMABio have expanded their manufacturing collaboration to support the clinical development of GB an investigational gene therapy for spinal muscular atrophy type SMA
Merck’s KEYTRUDA QLEX Approved for Subcutaneous Administration
Merck has announced that Japans Ministry of Health Labour and Welfare MHLW has approved KEYTRUDA QLEX pembrolizumab and berahyaluronidase alfapmph for subcutaneous administration